Diabetech - Diabetes Tech, Research, News

We cover ADCES 2025 updates on how diabetes educators are adapting to AI, new insights on mental health and eating disorders in type 1, and eye-opening stats about access to care. We also dive into the latest diabetes tech, including the Pivot pump, DIY systems, and carb awareness research. And lastly, we discuss major progress toward a cure for type 1 diabetes, with companies like Vertex and Sana moving faster than ever. I’m joine...

We dive into the growing off-label use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro among people with type 1 diabetes. I'm joined by longtime diabetes advocate and healthcare executive Marie Schiller to explore the benefits, risks, and evolving research around these drugs. We discuss new studies, including the ADJUST-T1D trial, showing improved A1C, increased time in range, reduced insulin needs, and moderate weight loss...

AI-powered food tracking is changing how people with diabetes count carbs and manage their glucose. In this episode, I speak with Aurelian Briner, CEO and co-founder of the SNAQ app—an AI-driven diabetes app that uses photos, voice notes, and machine learning to estimate carbs, log meals, and predict glucose spikes. We dive into how AI is transforming diabetes management, the importance of personalized insights, and the challenges ...

This episode explores the early days of diabetes data integration and the rise of open-source AID systems with Brandon Arbiter, Co-Founder and Acting CEO of Tidepool. Brandon shares how his passion for location data led to the creation of Tidepool, now a key platform in diabetes tech. We discuss the pivotal people who shaped the open source space, big moments in the development of AID systems, Tidepool’s role in FDA-clearing the Lo...

Dexcom addresses growing concerns over G7 sensor failures, the recall of receivers with faulty alerts, and an FDA warning letter. We also discuss the upcoming 15-day Dexcom G7, AI food tracking and a new integration between Stelo and Oura Ring. Drop your questions and comments on YouTube.

Join our Newsletter

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up  (US residents only)

Watch This Episode On You...

In this episode, Justin speaks with Melissa Holloway, the founder of SmartStart and a type 1 for over 30 years, opens up about her personal fight to access an insulin pump after moving to the UK—and how that journey led her to become a force for change in the diabetes community. Together, they explore how one voice can make a difference and why community-driven events like Friends for Life are so essential for families navigating t...

We break down the biggest diabetes tech and research highlights from the 2025 ADA Scientific Sessions. Justin is joined by CDCES Gary Scheiner to discuss new tubeless insulin pumps, an implantable continuous glucose monitor, and updates on a dual glucose-ketone sensor. We also explore cutting-edge research on islet cell therapies, ultra-concentrated insulins, and the potential of amylin as a complementary hormone treatment.

Learn...

In this live episode of Diabetech, I'm joined by Jen Greaves in Valencia, Spain! Jen is a fellow T1D, world traveler, and content creator who spent four months exploring Latin America—all while managing life with type 1. We talk about what it takes to travel long-term with T1D, from navigating insulin supply challenges to staying on top of tech and routines while constantly on the move. Now that I’ve been traveling as a digital nom...

Over the last 8 months, I’ve been traveling the world as a digital nomad, and I want everyone with diabetes to know—it is possible to travel safely and confidently. Today I'm joined by my diabetes educator, Mary Rose, who helped guide me through my very first trip with type 1 diabetes! Mary Rose and I cover everything from what to pack and how to prep with your care team, to airport security tips, managing insulin on long flights, ...

We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, and Dr. David Ahn, a practicing endocrinologist. We discuss the recent FDA warning le...

Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of adoption, and pivotal research that expanded global access. Plus, we look ahead to what ...

I sit down with someone who wore the first consumer insulin pump—the AutoSyringe We dive into what diabetes treatment was like at the time, how the early pump worked, and how decades of evolving tech have shaped her journey and inspired her to educate others. It’s a powerful look at how far we’ve come in diabetes innovation. 

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up  (US residents only)

Watch Thi...

I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. With early praise from endocrinologists and patients alike, this could be the educati...

Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device could offer over today’s CGMs. We cover how the sensor works, how it's implanted, and it...

I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from other pumps like the Omnipod. We also discuss David’s journey to becoming an educator...

We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families managing diabetes, and the powerful role the open-source community played in pushing the i...

In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at Beta Bionics, to break down what this transition means for people with diabetes. We ...

In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders, regulators, and patient voices come together to push diabetes tech forward. We talk...

Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially eliminating harmful side effects like serum sickness. We unpack how this treatment could d...